Table 1 Characteristics of colorectal carcinoma patients and prognostic effect on DFS and OVS.
From: Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma
| Number | (%) | DFS (months) | P value | OVS (months) | P value | |
|---|---|---|---|---|---|---|
| Age | ||||||
| 60≤ | 17 | 56.7 | 10.5 | 0.0184 | 34 | 0.216 |
| >60 | 13 | 43.3 | 18.9 | 48.4 | ||
| Sex | ||||||
| Female | 12 | 40 | 18.2 | 0.221 | 42.2 | 0.782 |
| Male | 18 | 60 | 11.5 | 39 | ||
| Tumor location | ||||||
| Colon | 24 | 80 | 10.1 | 0.0272 | 34.8 | 0.0111 |
| Rectum | 6 | 20 | 30.3 | 62 | ||
| Dukes Stage | ||||||
| A | - | |||||
| B | 8 | 26.7 | 25.7 | 0.0002 | 50.2 | 0.0076 |
| C | 11 | 36.7 | 17.8 | 48.4 | ||
| D | 11 | 36.7 | 2.18 | 24.9 | ||
| Histologic type | ||||||
| Adeno Ca | 27 | 90 | 14.92 | 0.455 | 42.55 | 0.0243 |
| Mucinous Ca | 1 | 3.3 | 10.0 | 13.0 | ||
| Adenosquamous Ca | 1 | 3.3 | 13.0 | 27.0 | ||
| Adenocarcinoid Ca | 1 | 3.3 | 0.0 | 20.0 | ||
| Differentiation | ||||||
| Well differentiated | 6 | 20 | 8.3 | 0.0407 | 46.3 | 0.002 |
| Moderately differentiated | 19 | 63.3 | 18.6 | 43.9 | ||
| Poorly differentiated | 4 | 13.3 | 5.5 | 21.7 | ||
| Colloid (mucinous) | 1 | 3.3 | 0.0 | 9 | ||
| Metastatic Lymph Node | ||||||
| Absent | 8 | 26.7 | 25.7 | 0.0398 | 50.25 | 0.259 |
| Present | 22 | 73.3 | 10.0 | 36.68 | ||
| Preoperative Metastasis | ||||||
| Absent | 19 | 64.3 | 21.1 | 0.000 | 49 | 0.0018 |
| Present | 11 | 36.6 | 2.18 | 24.91 | ||
| Serum MUC5AC Ab level | ||||||
| Negative | 12 | 40 | 19.91 | 0.153 | 50.0 | 0.052 |
| Positive | 18 | 60 | 10.38 | 33.83 |
